ONO PHARMACEUTICAL CO., LTD.【JP:4528】Cash flow
Market cap
¥1.13T
P/E ratio
15.9x
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | - | - | - | - | - | 9,213 | 10,621 | 14,214 | 15,820 | 17,721 | 17,451 | 18,140 | 26,894 |
| Cash from operations | 18,992 | 28,422 | 31,579 | 12,842 | 74,450 | 15,727 | 66,774 | 74,157 | 73,977 | 61,829 | 159,610 | 110,660 | 82,459 |
| Capital expenditures | - | - | - | - | - | -15,620 | -22,303 | -7,475 | -7,018 | -5,497 | -5,340 | -4,020 | -5,431 |
| Cash from investing | 4,365 | 6,926 | -12,756 | 13,037 | -17,989 | -34,189 | -49,763 | -10,234 | -57,586 | 6,038 | -100,259 | 48,077 | -136,785 |
| Payments for dividends | - | - | - | - | - | -23,414 | -21,828 | -22,775 | -22,449 | -27,666 | -29,742 | -37,183 | -37,516 |
| Repurchases of common stock | - | - | - | - | - | -38,773 | -1 | -29,584 | -3 | -30,007 | -1 | -50,010 | -1 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | - | - | - | - | 150,000 |
| Repayments of term debt | - | - | - | - | - | -417 | -361 | - | - | - | - | - | -15,000 |
| Cash from financing | -19,372 | -19,636 | -19,603 | -19,465 | -20,552 | -62,549 | -22,279 | -54,721 | -24,754 | -60,237 | -32,484 | -89,848 | 94,299 |